UPDATE: Roth Capital Downgrades Humanigen (HGEN) to Neutral
Tweet Send to a Friend
(Updated - July 13, 2022 9:02 AM EDT)
Roth Capital analyst Tony Butler downgraded Humanigen (NASDAQ: HGEN) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Tony Butler downgraded Humanigen (NASDAQ: HGEN) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


